Cargando…

Biotechnological and Immunological Platforms Based on PGL-I Carbohydrate-Like Peptide of Mycobacterium leprae for Antibodies Detection Among Leprosy Clinical Forms

Phenolic glycolipid I (PGL-I) is an abundant antigen on the Mycobacterium leprae cell wall, commonly used for operational classification of leprosy patients. Our aim was to develop PGL-I mimotopes with similar characteristics and functions of the native antigen. We have used a random peptide phage d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lima, Mayara Ingrid Sousa, Capparelli, Fausto Emilio, Dias Oliveira, Jaqueline das Dores, Fujimura, Patrícia Tiemi, Moraes, Emilly Caroline dos Santos, Araujo, Ester Cristina Borges, Silva, Neide Maria, Alves-Balvedi, Renata Pereira, Brito-Madurro, Ana Graci, Goulart, Isabela Maria Bernardes, Goulart, Luiz Ricardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092704/ https://www.ncbi.nlm.nih.gov/pubmed/32256479 http://dx.doi.org/10.3389/fmicb.2020.00429

Ejemplares similares

HSP60 mimetic peptides from Mycobacterium leprae as new antigens for immunodiagnosis of Leprosy
por: Lima, Mayara Ingrid Sousa, et al.
Publicado: (2023)

Innovative approaches to improve serodiagnosis of Strongyloides stercoralis infection
por: Levenhagen, Marcelo Arantes, et al.
Publicado: (2021)

Will cases of leprosy reaction increase with COVID-19 infection?
por: Antunes, Douglas Eulálio, et al.
Publicado: (2020)

Anti-Lipoarabinomannan-Specific Salivary IgA as Prognostic Marker for Leprosy Reactions in Patients and Cellular Immunity in Contacts
por: Nahas, André Alan, et al.
Publicado: (2018)

Frontiers of biology in human diseases: strategies for biomolecule's discovery, nanobiotechnologies and biophotonics
por: Goulart, Luiz, et al.
Publicado: (2014)

Clinical, epidemiological, and laboratory prognostic factors in patients with leprosy reactions: A 10-year retrospective cohort study
por: Antunes, Douglas Eulálio, et al.
Publicado: (2022)

qPCR-High resolution melt analysis for drug susceptibility testing of Mycobacterium leprae directly from clinical specimens of leprosy patients
por: Araujo, Sergio, et al.
Publicado: (2017)

Salivary anti-PGL-1 IgM may indicate active transmission of Mycobacterium leprae among young people under 16 years of age
por: Macedo, Alexandre Casimiro de, et al.
Publicado: (2017)

Differential Expression of IFN-γ, IL-10, TLR1, and TLR2 and Their Potential Effects on Downgrading Leprosy Reaction and Erythema Nodosum Leprosum
por: Antunes, Douglas Eulálio, et al.
Publicado: (2019)

Field-friendly anti-PGL-I serosurvey in children to monitor Mycobacterium leprae transmission in Bihar, India
por: Pierneef, Louise, et al.
Publicado: (2023)

Evaluation of the cutaneous sensation of the face in patients with different clinical forms of leprosy
por: de Oliveira, Marlice Fernandes, et al.
Publicado: (2019)

Revisiting primary neural leprosy: Clinical, serological, molecular, and neurophysiological aspects
por: dos Santos, Diogo Fernandes, et al.
Publicado: (2017)

Modulation of the Response to Mycobacterium leprae and Pathogenesis of Leprosy
por: Cabral, Natasha, et al.
Publicado: (2022)

PGL-III, a Rare Intermediate of Mycobacterium leprae Phenolic Glycolipid Biosynthesis, Is a Potent Mincle Ligand
por: Ishizuka, Shigenari, et al.
Publicado: (2023)

Longitudinal assessment of anti-PGL-I serology in contacts of leprosy patients in Bangladesh
por: Richardus, Renate A., et al.
Publicado: (2017)

Molecular, immunological and neurophysiological evaluations for early diagnosis of neural impairment in seropositive leprosy household contacts
por: dos Santos, Diogo Fernandes, et al.
Publicado: (2018)

Gene Expression Profile of Mycobacterium leprae Contribution in the Pathology of Leprosy Neuropathy
por: de Souza, Beatriz Junqueira, et al.
Publicado: (2022)

Phylogenomics and antimicrobial resistance of the leprosy bacillus Mycobacterium leprae
por: Benjak, Andrej, et al.
Publicado: (2018)

Anti-PGL-1 Positivity as a Risk Marker for the Development of Leprosy among Contacts of Leprosy Cases: Systematic Review and Meta-analysis
por: Penna, Maria Lucia F., et al.
Publicado: (2016)

Early Revelation of Leprosy in China by Sequential Antibody Analyses with LID-1 and PGL-I
por: Qiong-Hua, Pan, et al.
Publicado: (2013)

Latent leprosy infection identified by dual RLEP and anti-PGL-I positivity: Implications for new control strategies
por: da Silva, Moises Batista, et al.
Publicado: (2021)

Drug Resistance in Mycobacterium Leprae in the Context of Zero Leprosy
por: Singh, Itu, et al.
Publicado: (2021)

Mycobacterium leprae’s Infective Capacity Is Associated with Activation of Genes Involved in PGL-I Biosynthesis in a Schwann Cells Infection Model
por: Chavarro-Portillo, Bibiana, et al.
Publicado: (2023)

Type 2 leprosy reaction presenting as a monoarthritis post multidrug therapy
por: Goulart, Isabela Maria Bernardes, et al.
Publicado: (2022)

Leprosy transmission in endemic and non-endemic areas based on the profile of antibody response of PGL-1 and PCR detection of Mycobacterium leprae DNA from nasal swab among healthy children of East Java, Indonesia
por: Adriaty, Dinar, et al.
Publicado: (2020)

Mycobacterium leprae and host immune transcriptomic signatures for reactional states in leprosy
por: Das, Madhusmita, et al.
Publicado: (2023)

Detection of Mycobacterium leprae in saliva and the evaluation of oral sensitivity in patients with leprosy
por: da Rosa, Fernanda Borowsky, et al.
Publicado: (2013)

Type I Lepra Reaction as the Presenting Sign of Histoid Leprosy
por: Sun, Jingru, et al.
Publicado: (2017)

Autochthonous leprosy in Spain: Has the transmission of Mycobacterium leprae stopped?
por: Suárez-García, Inés, et al.
Publicado: (2020)

Assessment of neuropathic pain in leprosy patients with relapse or treatment failure by infrared thermography: A cross-sectional study
por: Tiago, Liliane Marques de Pinho, et al.
Publicado: (2021)

Performance of serological tests PGL1 and NDO-LID in the diagnosis of leprosy in a reference Center in Brazil
por: Leturiondo, André Luiz, et al.
Publicado: (2019)

Antigen-specific assessment of the immunological status of various groups in a leprosy endemic region
por: Fabri, Angélica da Conceição Oliveira Coelho, et al.
Publicado: (2015)

Electrochemical evaluation of anti-CRP/CRP interaction for the molecular diagnosis of the cardiovascular risk
por: Rodovalho, Vinícius, et al.
Publicado: (2014)

Identification of clinical, epidemiological and laboratory risk factors for leprosy reactions during and after multidrug therapy
por: Antunes, Douglas Eulálio, et al.
Publicado: (2013)

Detection of a Specific Biomarker for Epstein-Barr Virus Using a Polymer-Based Genosensor
por: Balvedi, Renata P. A., et al.
Publicado: (2014)

Expression of NLRP3 inflammasome in leprosy indicates immune evasion of Mycobacterium leprae
por: Mendes, Ana Luisa Gomes, et al.
Publicado: (2020)

Impact of PGL-I Seropositivity on the Protective Effect of BCG Vaccination among Leprosy Contacts: A Cohort Study
por: Düppre, Nádia C., et al.
Publicado: (2012)

CR3 Engaged by PGL-I Triggers Syk-Calcineurin-NFATc to Rewire the Innate Immune Response in Leprosy
por: Doz-Deblauwe, Émilie, et al.
Publicado: (2019)

In search of biomarkers for leprosy by unraveling the host immune response to Mycobacterium leprae
por: van Hooij, Anouk, et al.
Publicado: (2021)

A Case of Borderline Tuberculoid Leprosy With Type One Lepra Reaction
por: Harikrishna, Ganaraja V, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_09j5k5jnjvma1mj7m3ifgbi45q